Skip to main content
Table of Contents
Print

Are There Dangerous Cannabis Interactions with CPAP Use for Sleep Apnoea? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Continuous positive airway pressure (CPAP) remains the gold standard for sleep apnoea treatment. With the growing use of cannabis, questions arise about potential cannabis and CPAP interaction. Understanding these interactions is essential for patient safety. 

Potential Concerns 

While cannabis does not directly interfere with CPAP devices, it may influence sleep patterns, sedation, and airway muscle tone, which could alter treatment effectiveness. Clinicians and patients should be aware of possible issues when combining therapies. 

Altered Sleep Architecture 

Cannabis can modify REM and NREM sleep, potentially affecting how CPAP with cannabis risk manifests during therapy. This may influence the number of apnoea events detected and patient adherence. 

Sedation and Daytime Sleepiness 

Excessive cannabis use could increase sedation, impacting the perceived benefit of CPAP. Monitoring cannabis with CPAP safety ensures patients are not over-sedated while using their devices. 

Airway Muscle Tone 

Cannabinoids may influence upper airway tone, which could theoretically modify CPAP pressure needs. Awareness of cannabis and CPAP interaction can guide clinicians in optimising therapy settings. 

Current evidence suggests minimal direct device interference, but CPAP with cannabis risk remains relevant for sleep quality and adherence. Considering cannabis with CPAP safety helps maintain effective OSA management while using cannabis therapeutically. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories